Merus N.V. announced updated interim clinical data on MCLA-129 from ongoing expansion cohorts in non-small cell lung cancer and in previously treated head and neck squamous cell carcinoma were presented at the European Society for Medical Oncology Asia Congress 2023.
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced agenda topics for its Investor R&D Day.
IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023 Read More »
UCB announced data being presented at the American Epilepsy Society Annual Meeting, taking place December 1–5 in Orlando, Florida, that focus on the real-world experiences of people living with rare epilepsy syndromes and their caregivers, in addition to several other presentations of clinical data evaluating the efficacy, safety and tolerability of FINTEPLA as a treatment
Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced it will provide updates on its neurology programs at the Annual Meeting of the American Epilepsy Society.
Shanghai Junshi Biosciences Co., Ltd announced that the TGA has accepted the NCE application for toripalimab in combination with cisplatin and gemcitabine, for the first-line treatment of adults with metastatic or recurrent locally advanced NPC, and for toripalimab, as a single agent, for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease
Everest Medicines announced that China National Medical Products Administration has accepted its investigational new drug application for zetomipzomib in China.
This week, the FDA could approve the first CRISPR-edited therapy in the U.S., while two other companies await decisions on topical drugs.
FDA Action Alert: Vertex/CRISPR, Arcutis and Optinose Read More »
For forms of Alzheimer’s, frontotemporal dementia and Parkinson’s caused by genetic defects, gene therapy could change the treatment landscape.
Opinion: The Transformative Potential of Gene Therapy for Neurodegenerative Diseases Read More »
From the skin to the lungs to the central nervous system, biotech companies are making progress toward delivering RNA therapeutics to multiple targets throughout the body. But challenges remain.
Los préstamos son la forma convencional de obtener un financiamiento de entidades bancarias, y pueden tener distintos propósitos, según los objetivos particulares del cliente. Sin embargo, los métodos tradicionales para la solicitud de créditos pueden res …
